C-Reactive Protein for Cardiovascular Risk Assessment
- Mona A. Kholeif, MD, FRCP, FESC
- Department of Medicine, King Abdul Aziz Medical City, Jeddah, Kingdom of Saudi Arabia
- Address correspondence to Dr. Mona A. Kholeif, Consultant Cardiologist, Cardiology Section, Department of Medicine, King Abdul Aziz Medical City, P.O. Box 9515, Jeddah 21423, Kingdom of Saudi Arabia. E-mail: kholeifm{at}ngha.med.sa
Malik et al. (1) report on the usefulness of C-reactive protein (CRP) in stratifying risk in patients with the metabolic syndrome and diabetes.
Studies on normal volunteers showed intraindividual variability, which in ∼50% of individuals was sufficient to change their CRP-related risk category (2).
Bogaty et al. (3) have also demonstrated what seems to be spontaneous fluctuation of CRP in stable patients with coronary artery disease …
